Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 22807504)

1.

Novel monoclonal antibody recognizing triglyceride-rich oxidized LDLs associated with severe liver disease and small oxidized LDLs in normal subjects.

Sakurai T, Ichikawa A, Furukawa H, Wada N, Nagasaka A, Takahashi Y, Fujikawa M, Ikuta A, Furumaki H, Shiga M, Shimizu C, Hui SP, Jin S, Takeda S, Fuda H, Nagasaka H, Kobayashi S, Chiba H.

Ann Clin Biochem. 2012 Sep;49(Pt 5):456-62. doi: 10.1258/acb.2012.011284. Epub 2012 Jul 17.

PMID:
22807504
2.

Immunological detection of large oxidized lipoproteins in hypertriglyceridemic serum.

Sakurai T, Wada N, Takahashi Y, Ichikawa A, Ikuta A, Furumaki H, Hui SP, Jin S, Takeda S, Fuda H, Fujikawa M, Shimizu C, Nagasaka H, Furukawa H, Kobayashi S, Chiba H.

Ann Clin Biochem. 2013 Sep;50(Pt 5):465-72. doi: 10.1177/0004563212473446. Epub 2013 Jul 15.

PMID:
23858503
3.

Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease.

Chiu HC, Jeng JR, Shieh SM.

Biochim Biophys Acta. 1994 Jan 11;1225(2):200-8.

PMID:
8280789
4.
5.
6.

Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody.

Itabe H, Yamamoto H, Imanaka T, Shimamura K, Uchiyama H, Kimura J, Sanaka T, Hata Y, Takano T.

J Lipid Res. 1996 Jan;37(1):45-53.

7.
8.

Differential toxicities of air (mO-LDL) or copper-oxidized LDLs (Cu-LDL) toward endothelial cells.

Furman C, Martin-Nizard F, Fruchart JC, Duriez P, Teissier E.

J Biochem Mol Toxicol. 1999;13(6):316-23.

PMID:
10487419
9.

Characterization of the epitopes specific for the monoclonal antibody 9F5-3a and quantification of oxidized HDL in human plasma.

Nakajima T, Matsunaga T, Kawai S, Hokari S, Inoue I, Katayama S, Nagata A, Komoda T.

Ann Clin Biochem. 2004 Jul;41(Pt 4):309-15.

PMID:
15298743
10.

Well-defined regions of apolipoprotein B-100 undergo conformational change during its intravascular metabolism.

Wang X, Pease R, Bertinato J, Milne RW.

Arterioscler Thromb Vasc Biol. 2000 May;20(5):1301-8.

11.

Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice.

Maor I, Hayek T, Coleman R, Aviram M.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2995-3005.

12.

Associations of LDL size with in vitro oxidizability and plasma levels of in vivo oxidized LDL in Type 2 diabetic patients.

Scheffer PG, Bos G, Volwater HG, Dekker JM, Heine RJ, Teerlink T.

Diabet Med. 2003 Jul;20(7):563-7.

PMID:
12823238
13.

Copper and myeloperoxidase-modified LDLs activate Nrf2 through different pathways of ROS production in macrophages.

Calay D, Rousseau A, Mattart L, Nuyens V, Delporte C, Van Antwerpen P, Moguilevsky N, Arnould T, Boudjeltia KZ, Raes M.

Antioxid Redox Signal. 2010 Nov 15;13(10):1491-502. doi: 10.1089/ars.2009.2971.

PMID:
20446765
15.
16.

Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?

Verhoye E, Langlois MR; Asklepios Investigators.

Clin Chem Lab Med. 2009;47(2):128-37. doi: 10.1515/CCLM.2009.037. Review.

PMID:
19099526
17.

Oxidized LDL from subjects with different dietary habits modifies atherogenic processes in endothelial and smooth muscle cells.

Lähteenmäki TA, Seppo L, Laakso J, Korpela R, Vanhanen H, Tikkanen MJ, Vapaatalo H.

Life Sci. 2000;66(5):455-65.

PMID:
10670834
18.
20.

Reduced susceptibility to oxidation of low-density lipoprotein in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome).

Calò L, Sartore G, Bassi A, Basso C, Bertocco S, Marin R, Zambon S, Cantaro S, D'Angelo A, Davis PA, Manzato E, Crepaldi G.

J Hypertens. 1998 Jul;16(7):1001-8.

PMID:
9794741
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk